Li‐Chun Lu
Impact in
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
Papers in
- Oncology 26
- Cancer Immunotherapy and Biomarkers 14
- Pancreatic and Hepatic Oncology Research 7
- Hepatology 20
- Hepatocellular Carcinoma Treatment and Prognosis 20
- Co-authors
- Ann‐Lii Cheng (28 shared papers)Chih‐Hung Hsu (29 shared papers)Yu‐Yun Shao (23 shared papers)Chiun Hsu (11 shared papers)Chun‐Jung Chang (3 shared papers)Tsung‐Hao Liu (10 shared papers)Ronnie T.P. Poon (1 shared paper)Antonios G. Mikos (2 shared papers)
- Journals
- Liver Cancer (4 papers)Oncology (4 papers)Cancer Research (2 papers)Journal of Biomedical Materials Research (2 papers)Cancer (1 paper)
- Partner nations
- TaiwanChinaUnited States
In The Last Decade
Li‐Chun Lu
54 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 89
- Hepatology 419
- Oncology 419
- Cancer Research 170
- Pathology and Forensic Medicine 153
- Immunology 154
Countries citing papers authored by Li‐Chun Lu
This map shows the geographic impact of Li‐Chun Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li‐Chun Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li‐Chun Lu more than expected).
Fields of papers citing papers by Li‐Chun Lu
This network shows the impact of papers produced by Li‐Chun Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li‐Chun Lu. The network helps show where Li‐Chun Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Li‐Chun Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 60 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 104 | |
| 2 | 2019 | 76 | |
| 3 | 2019 | 62 | |
| 4 | 1998 | 58 | |
| 5 | 1999 | 57 | |
| 6 | 2019 | 53 | |
| 7 | 2002 | 53 | |
| 8 | 2017 | 51 | |
| 9 | 2014 | 46 | |
| 10 | 2016 | 45 | |
| 11 | 2018 | 44 | |
| 12 | 2022 | 40 | |
| 13 | 2014 | 39 | |
| 14 | 2013 | 38 | |
| 15 | Metastasectomy of Krukenberg tumors may be associated with survival benefits in patients with metastatic gastric cancer. | 2012 | 38 |
| 16 | 2015 | 30 | |
| 17 | 2022 | 27 | |
| 18 | 2012 | 27 | |
| 19 | 2021 | 26 | |
| 20 | 2011 | 26 |
About Li‐Chun Lu
Li‐Chun Lu is a scholar working on Oncology, Hepatology, Molecular Biology, Surgery and Pathology and Forensic Medicine, having authored 60 papers that have together received 1.2k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (20 papers), Cancer Immunotherapy and Biomarkers (14 papers), Pancreatic and Hepatic Oncology Research (7 papers), Cancer Mechanisms and Therapy (6 papers), Immune cells in cancer (5 papers), Lung Cancer Treatments and Mutations (4 papers), Cancer, Lipids, and Metabolism (3 papers) and Wnt/β-catenin signaling in development and cancer (3 papers). The work is most often cited by research in Hepatology (419 citations), Oncology (419 citations), Cancer Research (170 citations), Pathology and Forensic Medicine (153 citations) and Immunology (154 citations). Li‐Chun Lu has collaborated with scholars based in Taiwan, China and United States. Frequent co-authors include Ann‐Lii Cheng, Chih‐Hung Hsu, Yu‐Yun Shao, Chiun Hsu, Chun‐Jung Chang, Tsung‐Hao Liu, Ronnie T.P. Poon, Antonios G. Mikos, Ying‐Chun Shen and M. Conley Wake. Their work appears in journals such as Liver Cancer, Oncology, Cancer Research, Journal of Biomedical Materials Research and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.